Ophthalmic lens with a microfluidic system

US10213140B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10213140-B2
Application numberUS-201313896708-A
CountryUS
Kind codeB2
Filing dateMay 17, 2013
Priority dateMay 17, 2013
Publication dateFeb 26, 2019
Grant dateFeb 26, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention described a system for an energized ophthalmic device with a media insert that includes microfluidic elements upon or within the media insert. In some embodiments, the microfluidic elements may be useful for the purpose of analyzing an analyte such as glucose in a fluid sample. In addition, some embodiments can function with a medicament administering device to treat an abnormal condition identified during the analyte analysis in the fluid sample.

First claim

Opening claim text (preview).

The invention claimed is: 1. An ophthalmic device, including an ocular fluid analysis system, comprising: an ophthalmic device body; a media insert encapsulated within the ophthalmic device body, wherein the media insert comprises a first annular insert piece attached to and sealed together with a second annular insert piece to form an annular shaped insert having an annular cavity between the first annular insert piece and the second annular insert piece, an energy source within the cavity and configured to provide energy to the ocular fluid analysis system, a microfluidic analytical system within the cavity and in electrical communication with the energy source, wherein the microfluidic analytical system comprises a micro-channel for receiving and transporting fluid and is configured operatively to measure one or more properties of an ocular fluid sample flowed through the micro-channel; and, a processor within the cavity and configured to execute a program including preprogrammed threshold values for one or more of the ocular fluid properties and to output a signal when the received measurements are outside the corresponding preprogrammed threshold values; the media insert further comprises an opening into the cavity that exposes the micro-channel of the microfluidic analytical system to a user's ocular fluid that is external to the ophthalmic device. 2. The ophthalmic device of claim 1 , wherein: the outputted signal can cause the activation of a medicament administering device capable of administering a medicament based on outputted signal. 3. The ophthalmic device of claim 1 , additionally comprising: an artificial pore controlling a fluid path leading to a microfluidic pump component. 4. The ophthalmic device of claim 3 , wherein: the microfluidic pump component operates using electrowetting of dielectric principles. 5. The ophthalmic device of claim 3 , wherein: the microfluidic pump component operates using electrophoresis principles. 6. The ophthalmic device of claim 1 , wherein: the microfluidic analytical system operates to perform biochemical analysis of an ocular fluid sample in an interactive environment on a microchip sized wafer. 7. The ophthalmic device of claim 1 , wherein: the ophthalmic device body is a hydrogel contact lens. 8. The ophthalmic device of claim 1 , wherein: the preprogrammed threshold values are normal glucose concentration levels in an ocular fluid sample. 9. The ophthalmic device of claim 8 , wherein: the ocular fluid sample is a tear fluid sample. 10. The ophthalmic device of claim 1 , wherein the media insert has a circular peripheral edge with a diameter that is less than the diameter of the ophthalmic body and is positioned within the ophthalmic body such that the center of the media insert is aligned with the center of the ophthalmic body. 11. The ophthalmic device of claim 1 , wherein the media insert is in direct contact with an anterior surface of the eye. 12. The ophthalmic device of claim 1 , wherein the media insert is encapsulated in a semi-permeable membrane to selectively permit substances to penetrate or escape the media insert. 13. The ophthalmic device of claim 1 , wherein the ocular fluid analysis system includes a pore and a pore control element connected to the microfluidic analytical system and configured to permit emission of monitored ocular fluid from the ophthalmic device.

Assignees

Inventors

Classifications

  • Intraocular lenses · CPC title

  • Tear or lachrymal fluid · CPC title

  • implantable in, or in contact with, the eye, e.g. ocular inserts · CPC title

  • Additional features not otherwise provided for · CPC title

  • Devices for taking samples of body liquids · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10213140B2 cover?
The present invention described a system for an energized ophthalmic device with a media insert that includes microfluidic elements upon or within the media insert. In some embodiments, the microfluidic elements may be useful for the purpose of analyzing an analyte such as glucose in a fluid sample. In addition, some embodiments can function with a medicament administering device to treat an ab…
Who is the assignee on this patent?
Johnson & Johnson Vision Care
What technology area does this patent fall under?
Primary CPC classification A61B5/14532. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Feb 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).